|
Ayush Quality Mark to serve as a global benchmark for authenticity & excellence: Experts
|
|
Shardul Nautiyal, Mumbai
January 07 , 2026
|
|
|
Companies with valid accreditations or certifications to global standards like WHO GMP or ISO or equivalent standards will be eligible for the Ayush Quality Mark through a streamlined, desk-based review. This approach supports ‘ease of doing business’ by avoiding duplicate inspections, according to Ayush Export Promotion Council (Ayushexcil) experts.
The primary goal is to establish a unified brand that instils consumer trust worldwide, enhances India’s credibility in exports, and positions ‘Brand Ayush’ as a leader in the global traditional medicine sector.
Ayush Quality Mark, a comprehensive recognition programme, is designed to serve as a global benchmark for authenticity and excellence. The core principle is to recognize and consolidate existing national and international certifications, explains Ayushexcil expert Dr Tripta Dixit.
Ayushexcil has been appointed as the nodal agency to implement and issue the Ayush Quality Mark. The mark will initially cover a wide array of seven categories, including Ayush medicinal products, botanicals, herbs, product testing laboratories, hospitals, day-care centres, clinics, wellness centres, and medical value travel facilitators, with plans to include training and education institutions in the future.
This initiative, launched by the Prime Minister on December 19, 2025, represents a joint commitment by the government and industry to make the Ayush Quality Mark a definitive symbol of quality and global competitiveness. It is a forward-thinking initiative to unify these diverse quality assurances under a single, powerful global symbol.
“By recognizing existing accreditations/certifications, it will streamline compliance and support ease of doing business. This collaborative effort between the government and industry is set to cement Brand Ayush on the world stage, ensuring that India's ancient wisdom is delivered with an unwavering promise of modern safety, efficacy, and trust,” Dr Dixit says.
The Government of India, through the Ministry of Ayush, is making efforts to ensure that every Ayush product and services meet the highest standards of purity, efficacy, and safety, building a foundation of trust for consumers worldwide. The establishment of the dedicated Ministry of Ayush in 2014 was a pivotal moment, creating a central body to regulate and promote these ancient sciences with modern scientific validation.
The Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H) is the apex body for setting standards. So far, 2799 formulary specifications and 426 quality standards of Ayurveda, Siddha and Unani (ASU) formulations have been developed and published in different parts of Formularies and Pharmacopoeias respectively. Each monograph is a scientific document detailing the identity, purity, strength, and quality parameters for a specific raw drug or formulation. This provides a legal and scientific benchmark for manufacturers, ensuring consistency from batch to batch.
Experts inform that compliance with Good Manufacturing Practices (GMP) is mandatory for all Ayush manufacturing units in India. The Drugs and Cosmetics Rules, 1945, include Schedule T which lays down specific requirements for factory premises, equipment, raw material quality, and documentation for ASU (Ayurveda, Siddha, Unani) drugs. This ensures that the entire manufacturing process, from raw herbs to finished product, is controlled and validated.
Dr Dixit further informs that the Ministry of Ayush is continuously innovating and investing in new initiatives to further strengthen the quality ecosystem, directly addressing the key areas needed for global leadership. Ensuring quality begins at the source and the integrity of the raw material is paramount. The National Medicinal Plants Board (NMPB) has been a game-changer. It actively promotes Good Agricultural and Collection Practices (GACPs) to ensure that medicinal plants are cultivated and harvested sustainably and without contamination and operates a Voluntary Certification Scheme for Medicinal Plant Produce in partnership with the Quality Council of India.
The NMPB has supported the establishment of 4 state-of-the-art regional raw drug repositories (RRDRs) and 1 national raw drug repositories (NRDRs). These repositories authenticate raw materials, creating a reference library to combat adulteration. Furthermore, the e-Charak mobile app and portal directly connects farmers with manufacturers, ensuring better prices for cultivators and traceable, high-quality raw materials for the industry.
Modern science is being leveraged to validate ancient knowledge and for this the government implemented Central Sector Scheme Ayush Oushadhi Gunvatta Evam Uttpadan Samvardhan Yojana (AOGUSY) with financial allocation of Rs. 122 crore for five years in upgrading Drug Testing Laboratories, strengthening regulatory framework and supporting the establishment of world-class research facilities.
The monumental achievement has been the establishment of the WHO Global Centre for Traditional Medicine (GCTM) in Jamnagar, Gujarat. It is the world's first and only global outpost for traditional medicine, positioning India as the undisputed leader in evidence-based research and data documentation for traditional wellness systems. This centre will focus on creating a global repository of traditional medicine knowledge and setting international standards.
|
|
|
|
|
|
|
|
TOPICS
|
The Food and Drug Administration (FDA), Maharashtra, has issued a public advisory urging citizens to report any misleadi ...
|
|
|
|
|